Excessive perspiration or sweating, known as hyperhidrosis is a common problem which can be a real social and professional handicap.
Sweat is secreted by the 3 million sweat glands in our body.
Perspiration is an essential part of our body’s thermoregulation. The body’s thermostat is the hypothalamus. When the body’s temperature exceeds a certain temperature, the sweating process is triggered. A change to this mechanism can cause hyperhidrosis.
Cases of hyperhidrosis are classified as generalised, localised unilateral and localised bilateral cases.
Even though basic hyperhidrosis is very common (without any cause), a clinical examination to establish general medical conditions is essential before treatment of hyperhidrosis can begin.
The FDA has recognized Miradry as the technique for "permanent reduction of perspiration".
The device destroys the sweat glands by thermal action. The sweat glands do not reform over the course of life.
In order to provide medical information of an objective nature and for a scientific, preventive or educational purpose, it is added that botulinum toxin has been granted marketing authorization (MA) for the treatment of axillary hyperhydrosis on 18 July 2003 (source, document of the Haute Autorité de Santé ‘Injection session botulinum toxin in the face ‘October 2006). HAS has given the MA for severe axillary hyperhidrosis that has resisted local treatment and has significant psychological and social impact.
This acts by blocking the sweat glands’ action. Perspiration is blocked during 6 months.
BEFORE AND AFTER PICTURES